Article(id=1327673146058060316, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672996740837680, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2022.05.008, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1626278400000, receivedDateStr=2021-07-15, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794471544994, onlineDateStr=2026-11-12, pubDate=1652112000000, pubDateStr=2022-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794471544994, onlineIssueDateStr=2026-11-12, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794471544994, creator=13701087609, updateTime=1794471544994, updator=13701087609, issue=Issue{id=1327672996740837680, tenantId=1146029695717560320, journalId=1319690259887390882, year='2022', volume='53', issue='5', pageStart='592', pageEnd='762', issueExtLink='null', onlineDate='null', pubDate='1652112000000', pubDateStr='2022-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794471509393, creator='13701087609', updateTime=1794472241118, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1327676066405134338, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672996740837680, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1327676066405134339, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327672996740837680, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=652, endPage=657, ext={EN=ArticleExt(id=1327673146263581214, articleId=1327673146058060316, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=General Considerations on Pharmaceutical Development of Generic Oral Modified-release Formulations of Bupropion Hydrochloride, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

At present, the oral modified-release preparations of bupropion hydrochloride have been widely used in antidepressant treatment, and the development of their generic drugs has also become one of the hot spots. There are great differences in the formulation process and quality control of different modified-release preparations. Based on analysis of relevant literature and the dossiers, some key points of the formulation process and quality control of oral bupropion hydrochloride modified-release preparations are discussed, and some general considerations about pharmaceutical studies are put forward, in order to provide certain references for the R&D of generic drugs. It's recommended to take clinical needs into account and conduct further in-depth pharmaceutical studies in combination with characteristics of drug substances and excipients as well as drug release mechanisms to ensure the consistency in quality and efficacy between the generic and reference drugs.

, authors=Xiaofei SI, Zhongheng ZHANG, Dianzhuo JIANG*, authorsList=Xiaofei SI, Zhongheng ZHANG, Dianzhuo JIANG, authorCompany=null, correspAuthors=Dianzhuo JIANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1327673146880143903, articleId=1327673146058060316, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=盐酸安非他酮口服调释制剂仿制药开发中药学研究的一般考虑, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

目前盐酸安非他酮的口服调释制剂已广泛应用于抗抑郁治疗,其仿制药的研发申报也成为一个热点,但不同的调释制剂在处方工艺、质量控制等方面存在较大差异。本研究基于文献调研及对目前申报资料的分析,从盐酸安非他酮口服调释制剂的处方工艺和质量控制角度,提出了仿制药药学研究的一般考虑,以期对该类仿制药物的研发和注册申报提供一定参考。建议考虑临床用药需求,结合原辅料性质、制剂释药机制等多方面因素,深入进行药学研究,以保证盐酸安非他酮口服调释制剂与参比制剂的质量和疗效一致性。

, authors=司晓菲, 张仲恒, 姜典卓*, authorsList=司晓菲, 张仲恒, 姜典卓, authorCompany=null, correspAuthors=姜典卓, authorNote=

司晓菲(1989—),女,主管药师,从事化学药品技术审评工作。

, correspAuthorsNote=
姜典卓(1978—),男,副主任药师,从事化学药品技术审评工作。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=ufyuKiElv3UWo4eYdwtdWw==, magXml=FL0PeIrx6znT90NyXydQSw==, pdfUrl=null, pdf=mmUtlB2dm9KTdrxW3ob78g==, pdfFileSize=1430238, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=BYiAls5g8aJJ36fa4sY/wQ==, mapNumber=null, fund=null)}, authors=[Author(id=1327673147152773668, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673147245048358, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, authorId=1327673147152773668, language=EN, stringName=Xiaofei SI, firstName=Xiaofei, middleName=null, lastName=SI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673147328934439, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, authorId=1327673147152773668, language=CN, stringName=司晓菲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

司晓菲(1989—),女,主管药师,从事化学药品技术审评工作。

"}, bioImg=null, bioContent=

司晓菲(1989—),女,主管药师,从事化学药品技术审评工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673147077276192, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, xref=null, ext=[AuthorCompanyExt(id=1327673147081470497, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327673147094053410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327673147404431913, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673147496706603, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, authorId=1327673147404431913, language=EN, stringName=Zhongheng ZHANG, firstName=Zhongheng, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673147555426860, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, authorId=1327673147404431913, language=CN, stringName=张仲恒, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673147077276192, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, xref=null, ext=[AuthorCompanyExt(id=1327673147081470497, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327673147094053410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327673147609952814, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=jiangdzh@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327673147681255984, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, authorId=1327673147609952814, language=EN, stringName=Dianzhuo JIANG, firstName=Dianzhuo, middleName=null, lastName=JIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673147731587633, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, authorId=1327673147609952814, language=CN, stringName=姜典卓, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673147077276192, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, xref=null, ext=[AuthorCompanyExt(id=1327673147081470497, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327673147094053410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])], keywords=[Keyword(id=1327673147807085106, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, language=EN, orderNo=1, keyword=depression), Keyword(id=1327673147882582579, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, language=EN, orderNo=2, keyword=modified-release preparation), Keyword(id=1327673147949691444, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, language=EN, orderNo=3, keyword=bupropion hydrochloride), Keyword(id=1327673148012606005, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, language=EN, orderNo=4, keyword=generic drug), Keyword(id=1327673148083909174, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, language=CN, orderNo=1, keyword=抑郁症), Keyword(id=1327673148142629431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, language=CN, orderNo=2, keyword=调释制剂), Keyword(id=1327673148205543992, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, language=CN, orderNo=3, keyword=盐酸安非他酮), Keyword(id=1327673148268458553, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, language=CN, orderNo=4, keyword=仿制药)], refs=[Reference(id=1327673148373316154, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=WHO.Depression [EB/OL].[2021-07-13].https://www.who.int/news-room/fact-sheets/detail/depression., articleTitle=null, refAbstract=null), Reference(id=1327673148482368059, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=健康中国行动推进委员会.健康中国行动(2019—2030年)[EB/OL].[2021-07-13].http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm., articleTitle=null, refAbstract=null), Reference(id=1327673148570448444, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Wellbutrin XL® (bupropion hydrochloride extended-release) tablets for oral use [EB/OL].[2021-07-13].https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021515s040lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1327673148645945917, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms [EB/OL].(2014-11-20)[2021-07-13].https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmacokinetic-clinical-evaluation-modified-release-dosage-forms_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1327673148746609214, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Bioavailability and bioequivalence studies submitted in NDAs or INDs - general considerations [EB/OL].[2021-07-13].https://www.fda.gov/media/88254/download., articleTitle=null, refAbstract=null), Reference(id=1327673148952130112, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Wellbutrin SR (bupropion hydrochloride) sustained-release tablets, for oral use [EB/OL].[2021-07-13].https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020358s064lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1327673149036016193, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=宫艳畅,杨白雪,孙瑞濛,等.羟丙甲纤维素的来源差异对其性质及功能性的影响[J].中国医药工业杂志,2020,51(9):1178-1183., articleTitle=null, refAbstract=null), Reference(id=1327673149128290882, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=张敬真,张雪梅,丁嘉信,等.羟丙甲纤维素的关键质量属性对双氯芬酸钠缓释片体外释放的影响[J].中国药学杂志,2019,54(5):382-389., articleTitle=null, refAbstract=null), Reference(id=1327673149199594051, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=RUFF M D, KALIDINDI S R, SUTTON J E Jr.Pharmaceutical composition containing bupropion hydrochloride and a stabilizer: US, 5358970 [P].1994-10-25., articleTitle=null, refAbstract=null), Reference(id=1327673149287674436, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=LUDWIG J S G, BASS W L Jr, SUTTON J S Jr.Controlled sustained release tablets containing bupropion: US,5427798[P].1995-06-27., articleTitle=null, refAbstract=null), Reference(id=1327673149371560517, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.21-515 CHEMISTRY REVIEW(S).Wellbutrin(bupropion hydrochloride) extended release tablets [EB/OL].(2003-08-28) [2021-07-13].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021515_Wellbutrin_chemr.PDF., articleTitle=null, refAbstract=null), Reference(id=1327673149451252294, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=SETH P.Delayed release coated tablet of bupropion hydrochloride: US, 6143327 [P].2000-11-07., articleTitle=null, refAbstract=null), Reference(id=1327673149535138375, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.化学仿制药注册批生产规模的一般性要求[EB/OL].(2018-06-22)[2021-07-13].https://www.cde.org.cn/main/news/viewInfoCommon/ed6b8e3c5c36edb40b1e19965092cfd7., articleTitle=null, refAbstract=null), Reference(id=1327673149614830152, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=MACCARONI E, MALPEZZI L, MASCIOCCHI N.Structures from powders: bupropion hydrochloride [J].J Pharm Biomed Anal, 2009, 50(2): 257-261., articleTitle=null, refAbstract=null), Reference(id=1327673149698716233, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=赵悦清,周仕海,柳文洁,等.口服固体制剂溶出方法建立和验证的技术探讨[J].药学学报,2018,53(2):202-209., articleTitle=null, refAbstract=null), Reference(id=1327673149782602315, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局.以药动学参数为终点评价指标的化学药物仿制药人体生物等效性研究技术指导原则[EB/OL].(2016-03-18)[2021-07-13].https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/ggtg/qtggtg/20160318210001725.html., articleTitle=null, refAbstract=null), Reference(id=1327673149849711180, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Draft guidance on bupropion hydrochloride [EB/OL].[2021-07-13].https://www.accessdata.fda.gov/drugsatfda_docs/psg/Bupropion_HCl_ERtab_20358_20711_RV03-13.pdf., articleTitle=null, refAbstract=null), Reference(id=1327673149904237133, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Draft guidance on bupropion hydrochloride [EB/OL].[2021-07-13].https://www.accessdata.fda.gov/drugsatfda_docs/psg/Bupropion_HCl_ERtab_21515_RV03-13.pdf., articleTitle=null, refAbstract=null), Reference(id=1327673149962957390, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Guideline on the investigation of bioequivalence[EB/OL].(2010-01-20)[2021-07-13].https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1327673150034260559, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.对我国《以药动学参数为终点评价指标的化学药物仿制药人体生物等效性研究技术指导原则》中关于多规格豁免BE药学评价标准“处方比例相似性”相关问题的问答(试行)[EB/OL].(2022-01-21)[2022-05-30].https://www.cde.org.cn/main/news/viewInfoCommon/d4b0c931e393e5a803d77ddc31383008., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1327673147077276192, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, xref=null, ext=[AuthorCompanyExt(id=1327673147081470497, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327673147094053410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.05.008, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.05.008, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2022.05.008, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2022.05.008, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1652112000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
盐酸安非他酮口服调释制剂仿制药开发中药学研究的一般考虑
司晓菲 , 张仲恒 , 姜典卓 *
中国医药工业杂志 | 综述 2022,53(5): 652-657
收起
收藏切换
中国医药工业杂志 |综述 2022 , 53 (5) : 652 -657
盐酸安非他酮口服调释制剂仿制药开发中药学研究的一般考虑
全屏
[Author(id=1327673147152773668, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673147245048358, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, authorId=1327673147152773668, language=EN, stringName=Xiaofei SI, firstName=Xiaofei, middleName=null, lastName=SI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673147328934439, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, authorId=1327673147152773668, language=CN, stringName=司晓菲, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

司晓菲(1989—),女,主管药师,从事化学药品技术审评工作。

"}, bioImg=null, bioContent=

司晓菲(1989—),女,主管药师,从事化学药品技术审评工作。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673147077276192, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, xref=null, ext=[AuthorCompanyExt(id=1327673147081470497, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327673147094053410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327673147404431913, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327673147496706603, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, authorId=1327673147404431913, language=EN, stringName=Zhongheng ZHANG, firstName=Zhongheng, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673147555426860, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, authorId=1327673147404431913, language=CN, stringName=张仲恒, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673147077276192, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, xref=null, ext=[AuthorCompanyExt(id=1327673147081470497, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327673147094053410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1327673147609952814, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=jiangdzh@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327673147681255984, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, authorId=1327673147609952814, language=EN, stringName=Dianzhuo JIANG, firstName=Dianzhuo, middleName=null, lastName=JIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327673147731587633, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, authorId=1327673147609952814, language=CN, stringName=姜典卓, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327673147077276192, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, xref=null, ext=[AuthorCompanyExt(id=1327673147081470497, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022), AuthorCompanyExt(id=1327673147094053410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327673146058060316, companyId=1327673147077276192, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])]
司晓菲, 张仲恒, 姜典卓*
作者信息
  • 国家药品监督管理局药品审评中心,北京 100022
通讯作者:
姜典卓(1978—),男,副主任药师,从事化学药品技术审评工作。E-mail:
作者简介:

司晓菲(1989—),女,主管药师,从事化学药品技术审评工作。

General Considerations on Pharmaceutical Development of Generic Oral Modified-release Formulations of Bupropion Hydrochloride
Xiaofei SI, Zhongheng ZHANG, Dianzhuo JIANG*
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100022
出版时间: 2022-05-10 doi: 10.16522/j.cnki.cjph.2022.05.008
文章导航
收藏切换

目前盐酸安非他酮的口服调释制剂已广泛应用于抗抑郁治疗,其仿制药的研发申报也成为一个热点,但不同的调释制剂在处方工艺、质量控制等方面存在较大差异。本研究基于文献调研及对目前申报资料的分析,从盐酸安非他酮口服调释制剂的处方工艺和质量控制角度,提出了仿制药药学研究的一般考虑,以期对该类仿制药物的研发和注册申报提供一定参考。建议考虑临床用药需求,结合原辅料性质、制剂释药机制等多方面因素,深入进行药学研究,以保证盐酸安非他酮口服调释制剂与参比制剂的质量和疗效一致性。

抑郁症  /  调释制剂  /  盐酸安非他酮  /  仿制药

At present, the oral modified-release preparations of bupropion hydrochloride have been widely used in antidepressant treatment, and the development of their generic drugs has also become one of the hot spots. There are great differences in the formulation process and quality control of different modified-release preparations. Based on analysis of relevant literature and the dossiers, some key points of the formulation process and quality control of oral bupropion hydrochloride modified-release preparations are discussed, and some general considerations about pharmaceutical studies are put forward, in order to provide certain references for the R&D of generic drugs. It's recommended to take clinical needs into account and conduct further in-depth pharmaceutical studies in combination with characteristics of drug substances and excipients as well as drug release mechanisms to ensure the consistency in quality and efficacy between the generic and reference drugs.

depression  /  modified-release preparation  /  bupropion hydrochloride  /  generic drug
司晓菲, 张仲恒, 姜典卓. 盐酸安非他酮口服调释制剂仿制药开发中药学研究的一般考虑. 中国医药工业杂志, 2022 , 53 (5) : 652 -657 . DOI: 10.16522/j.cnki.cjph.2022.05.008
Xiaofei SI, Zhongheng ZHANG, Dianzhuo JIANG. General Considerations on Pharmaceutical Development of Generic Oral Modified-release Formulations of Bupropion Hydrochloride[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (5) : 652 -657 . DOI: 10.16522/j.cnki.cjph.2022.05.008

参考文献 引证文献
排序方式:
[1]
WHO.Depression [EB/OL].[2021-07-13].https://www.who.int/news-room/fact-sheets/detail/depression.
[2]
健康中国行动推进委员会.健康中国行动(2019—2030年)[EB/OL].[2021-07-13].http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm.
[3]
FDA.Wellbutrin XL® (bupropion hydrochloride extended-release) tablets for oral use [EB/OL].[2021-07-13].https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021515s040lbl.pdf.
[4]
EMA.Guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms [EB/OL].(2014-11-20)[2021-07-13].https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmacokinetic-clinical-evaluation-modified-release-dosage-forms_en.pdf.
[5]
FDA.Bioavailability and bioequivalence studies submitted in NDAs or INDs - general considerations [EB/OL].[2021-07-13].https://www.fda.gov/media/88254/download.
[6]
FDA.Wellbutrin SR (bupropion hydrochloride) sustained-release tablets, for oral use [EB/OL].[2021-07-13].https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020358s064lbl.pdf.
[7]
宫艳畅,杨白雪,孙瑞濛,等.羟丙甲纤维素的来源差异对其性质及功能性的影响[J].中国医药工业杂志,2020,51(9):1178-1183.
[8]
张敬真,张雪梅,丁嘉信,等.羟丙甲纤维素的关键质量属性对双氯芬酸钠缓释片体外释放的影响[J].中国药学杂志,2019,54(5):382-389.
[9]
RUFF M D, KALIDINDI S R, SUTTON J E Jr.Pharmaceutical composition containing bupropion hydrochloride and a stabilizer: US, 5358970 [P].1994-10-25.
[10]
LUDWIG J S G, BASS W L Jr, SUTTON J S Jr.Controlled sustained release tablets containing bupropion: US,5427798[P].1995-06-27.
[11]
FDA.21-515 CHEMISTRY REVIEW(S).Wellbutrin(bupropion hydrochloride) extended release tablets [EB/OL].(2003-08-28) [2021-07-13].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021515_Wellbutrin_chemr.PDF.
[12]
SETH P.Delayed release coated tablet of bupropion hydrochloride: US, 6143327 [P].2000-11-07.
[13]
国家药品监督管理局药品审评中心.化学仿制药注册批生产规模的一般性要求[EB/OL].(2018-06-22)[2021-07-13].https://www.cde.org.cn/main/news/viewInfoCommon/ed6b8e3c5c36edb40b1e19965092cfd7.
[14]
MACCARONI E, MALPEZZI L, MASCIOCCHI N.Structures from powders: bupropion hydrochloride [J].J Pharm Biomed Anal, 2009, 50(2): 257-261.
[15]
赵悦清,周仕海,柳文洁,等.口服固体制剂溶出方法建立和验证的技术探讨[J].药学学报,2018,53(2):202-209.
[16]
国家药品监督管理局.以药动学参数为终点评价指标的化学药物仿制药人体生物等效性研究技术指导原则[EB/OL].(2016-03-18)[2021-07-13].https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/ggtg/qtggtg/20160318210001725.html.
[17]
FDA.Draft guidance on bupropion hydrochloride [EB/OL].[2021-07-13].https://www.accessdata.fda.gov/drugsatfda_docs/psg/Bupropion_HCl_ERtab_20358_20711_RV03-13.pdf.
[18]
FDA.Draft guidance on bupropion hydrochloride [EB/OL].[2021-07-13].https://www.accessdata.fda.gov/drugsatfda_docs/psg/Bupropion_HCl_ERtab_21515_RV03-13.pdf.
[19]
EMA.Guideline on the investigation of bioequivalence[EB/OL].(2010-01-20)[2021-07-13].https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf.
[20]
国家药品监督管理局药品审评中心.对我国《以药动学参数为终点评价指标的化学药物仿制药人体生物等效性研究技术指导原则》中关于多规格豁免BE药学评价标准“处方比例相似性”相关问题的问答(试行)[EB/OL].(2022-01-21)[2022-05-30].https://www.cde.org.cn/main/news/viewInfoCommon/d4b0c931e393e5a803d77ddc31383008.
2022年第53卷第5期
71
14
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2022.05.008
  • 接收时间:2021-07-15
  • 首发时间:2026-11-12
  • 出版时间:2022-05-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-07-15
基金
作者信息
    国家药品监督管理局药品审评中心,北京 100022

通讯作者:

姜典卓(1978—),男,副主任药师,从事化学药品技术审评工作。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.05.008
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏